Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression R33
Brief description of study
~60 subjects with MDD will undergo MRI scanning during t-PBM (administered with an irradiance of 291.7 mW/cm2 for 333s) before and after a randomized, double-blinded, controlled 16-session course of treatment with t-PBM or sham. t-PBM will be administered via NeuroThera’s LightForce® EXPi Deep Tissue Laser TherapyTM System, Transcranial PhotoBioModulation-1000 (tPBM-2.0).
Clinical Study Identifier: s22-01065
ClinicalTrials.gov Identifier: NCT05573074
Principal Investigator:
Dan Iosifescu.
Other Investigator:
Thaddeus Tarpey.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.